Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data
In the past decade, significant progress has been made in complex disease research across
multiple omics layers from genome, transcriptome and proteome to metabolome. There is an …
multiple omics layers from genome, transcriptome and proteome to metabolome. There is an …
Artificial intelligence for precision medicine in neurodevelopmental disorders
The ambition of precision medicine is to design and optimize the pathway for diagnosis,
therapeutic intervention, and prognosis by using large multidimensional biological datasets …
therapeutic intervention, and prognosis by using large multidimensional biological datasets …
An application of Random Forests to a genome-wide association dataset: methodological considerations & new findings
Background As computational power improves, the application of more advanced machine
learning techniques to the analysis of large genome-wide association (GWA) datasets …
learning techniques to the analysis of large genome-wide association (GWA) datasets …
Artificial intelligence for clinical decision support in neurology
Artificial intelligence is one of the most exciting methodological shifts in our era. It holds the
potential to transform healthcare as we know it, to a system where humans and machines …
potential to transform healthcare as we know it, to a system where humans and machines …
Second-generation digital health platforms: placing the patient at the center and focusing on clinical outcomes
Y Ilan - Frontiers in Digital Health, 2020 - frontiersin.org
Artificial intelligence (AI) digital health systems have drawn much attention over the last
decade. However, their implementation into medical practice occurs at a much slower pace …
decade. However, their implementation into medical practice occurs at a much slower pace …
Nutrigenomics research for personalized nutrition and medicine
J Kaput - Current opinion in biotechnology, 2008 - Elsevier
Current nutritional and genetic epidemiological methods yield 'risk factors' on the basis of
population studies. Risk factors, however, are statistical estimates of the percentage …
population studies. Risk factors, however, are statistical estimates of the percentage …
SNPs and somatic mutation on long non-coding RNA: new frontier in the cancer studies?
L Minotti, C Agnoletto, F Baldassari, F Corrà, S Volinia - High-throughput, 2018 - mdpi.com
In the last decade, it has been demonstrated that long non-coding RNAs (lncRNAs) are
involved in cancer development. The great majority of studies on lncRNAs report alterations …
involved in cancer development. The great majority of studies on lncRNAs report alterations …
The success of pharmacogenomics in moving genetic association studies from bench to bedside: study design and implementation of precision medicine in the post …
MD Ritchie - Human genetics, 2012 - Springer
Pharmacogenomics is emerging as a popular type of study for human genetics in recent
years. This is primarily due to the many success stories and high potential for translation to …
years. This is primarily due to the many success stories and high potential for translation to …
Comparison of approaches for machine‐learning optimization of neural networks for detecting gene‐gene interactions in genetic epidemiology
AA Motsinger‐Reif, SM Dudek… - … Official Publication of …, 2008 - Wiley Online Library
The detection of genotypes that predict common, complex disease is a challenge for human
geneticists. The phenomenon of epistasis, or gene‐gene interactions, is particularly …
geneticists. The phenomenon of epistasis, or gene‐gene interactions, is particularly …
Drug transporter and metabolizing enzyme gene variants and nonnucleoside reverse-transcriptase inhibitor hepatotoxicity
MD Ritchie, DW Haas, AA Motsinger… - Clinical Infectious …, 2006 - academic.oup.com
This nested case-control study examined relationships between MDR1, CYP2B6, and
CYP3A4 variants and hepatotoxicity during antiretroviral therapy with either efavirenz-or …
CYP3A4 variants and hepatotoxicity during antiretroviral therapy with either efavirenz-or …